Panacea Life Sciences Holdings Stock Forecast

Buy or Hold candidate since Jun 25, 2026 Gain 122.22%

The Panacea Life Sciences Holdings, Inc. stock price fell by -28.57% on the last day (Friday, 10th Jul 2026) from $0.140 to $0.100. During the last trading day the stock fluctuated 34.00% from a day low at $0.100 to a day high of $0.134. The price has risen in 6 of the last 10 days and is up by 122.22% over the past 2 weeks. Volume has increased on the last day by 15 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 23 thousand shares were bought and sold for approximately $2.31 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 51.11% during the next 3 months and, with a 90% probability hold a price between $0.0672 and $0.213 at the end of this 3-month period.

PLSH Signals & Forecast

The Panacea Life Sciences Holdings, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0985 and $0.0485. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -28.57%. Further fall is indicated until a new bottom pivot has been found. Panacea Life Sciences Holdings, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Panacea Life Sciences Holdings, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0800. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0340 between high and low, or 34.00%. For the last week, the stock has had daily average volatility of 16.51%.

Our recommended stop-loss: $0.0954 (-4.58%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PLSH) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Panacea Life Sciences Holdings, Inc. to open at $0.111, and during the day (based on 14 day Average True Range), to move between $0.0947 and $0.105, which gives a possible trading interval of +/-$0.0105 (+/-11.14%) up or down from last closing price. If Panacea Life Sciences Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 11.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.110 (10.00%) than the support at $0.0800 (20.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Panacea Life Sciences Holdings, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Panacea Life Sciences Holdings, Inc. stock to perform well in the short-term.

Current score: 1.257 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.111 ( 11.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk